COSMO Pharmaceuticals SA Defensive Interval Ratio
COSMO Pharmaceuticals SA defensive interval ratio. COSMO Pharmaceuticals SA (0RGI) has a Defensive Interval Ratio of 2972 days as of June 2026. Defensive assets of £201.11 Million (cash £-, short-term investments £164.41 Million, receivables £36.70 Million) cover 2972 days of daily cash needs of £67.66K/day. See COSMO Pharmaceuticals SA (0RGI) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of COSMO Pharmaceuticals SA (2004–2025)
Defensive interval ratio of COSMO Pharmaceuticals SA from 2004 to 2025. This chart shows how COSMO Pharmaceuticals SA's Defensive Interval Ratio has evolved across 21 annual periods from 2004 to 2025. As of June 2026, the ratio stands at 2972 days, meaning defensive assets of £201.11 Million can fund 2972 days of operations without new revenue. Check 0RGI asset resilience ratio to evaluate the company's liquid asset resilience ratio.
COSMO Pharmaceuticals SA Defensive Interval Ratio by Year (2004–2025)
COSMO Pharmaceuticals SA defensive interval ratio by year from 2004 to 2025. The table below presents the year-by-year Defensive Interval Ratio for COSMO Pharmaceuticals SA from 2004 to 2025, covering 21 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see COSMO Pharmaceuticals SA asset portfolio.
| Year | DIR (days) | Defensive Assets (GBP) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1323 days | £92.44 Million | £69.87K/day | £- | £66.84 Million | ▲ +1044 days |
| 2024 | 279 days | £36.93 Million | £132.24K/day | £- | £17.99 Million | ▼ -125 days |
| 2023 | 404 days | £28.45 Million | £70.45K/day | £- | £- | ▲ +233 days |
| 2022 | 171 days | £91.31 Million | £534.10K/day | £- | £52.70 Million | ▼ -656 days |
| 2021 | 827 days | £48.10 Million | £58.18K/day | £- | £23.65 Million | ▼ -76 days |
| 2020 | 903 days | £53.91 Million | £59.71K/day | £- | £26.91 Million | ▼ -3208 days |
| 2019 | 4111 days | £176.90 Million | £43.03K/day | £- | £157.82 Million | ▲ +3521 days |
| 2018 | 590 days | £24.82 Million | £42.04K/day | £- | £12.05 Million | ▼ -179 days |
| 2017 | 769 days | £40.95 Million | £53.24K/day | £- | £27.76 Million | ▼ -475 days |
| 2016 | 1244 days | £63.80 Million | £51.28K/day | £- | £48.84 Million | ▲ +342 days |
| 2015 | 902 days | £61.87 Million | £68.61K/day | £- | £45.06 Million | ▲ +720 days |
| 2014 | 181 days | £30.12 Million | £166.18K/day | £- | £25.33 Million | ▼ -4841 days |
| 2013 | 5022 days | £133.44 Million | £26.57K/day | £- | £121.82 Million | ▲ +4838 days |
| 2012 | 184 days | £7.53 Million | £40.94K/day | £- | £1.00 | ▼ -235 days |
| 2011 | 419 days | £11.83 Million | £28.24K/day | £- | £- | ▲ +254 days |
| 2010 | 165 days | £12.30 Million | £74.55K/day | £- | £101.00K | ▼ -344 days |
| 2009 | 509 days | £10.16 Million | £19.97K/day | £- | £139.00K | ▲ +486 days |
| 2008 | 22 days | £578.00K | £25.71K/day | £- | £- | ▲ +34 days |
| 2006 | -12 days | £-370.00K | £31.67K/day | £- | £- | ▼ -201 days |
| 2005 | 189 days | £6.30 Million | £33.28K/day | £- | £- | ▲ +56 days |
| 2004 | 133 days | £2.83 Million | £21.23K/day | £- | £- | — |